The up-regulation of IDO is associated with a significant reduction of CD3+ TICs [124], or with an increased number of regulatory T (Treg) cells in the metastatic carcinoma in lymph nodes (LNs) [122]. The gene discussed is IDO1; the disease is metastatic carcinoma.